These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30509076)

  • 1. Neoadjuvant therapy for ovarian cancer.
    Imyanitov EN
    Chin Clin Oncol; 2018 Dec; 7(6):54. PubMed ID: 30509076
    [No Abstract]   [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusion.
    Wallach RC
    Oncology (Williston Park); 2008 Nov; 22(13):1456; author reply 1456-7. PubMed ID: 19133602
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical debulking before or after chemotherapy: stemming the tide on ovarian cancer recurrence.
    Rueda BR; Tilly JL; Schorge JO
    Onkologie; 2010; 33(6):286-7. PubMed ID: 20523089
    [No Abstract]   [Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer.
    Wang PH
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):623-624. PubMed ID: 30342639
    [No Abstract]   [Full Text] [Related]  

  • 5. LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).
    Eisenkop SM
    Gynecol Oncol; 2004 Mar; 92(3):1017-8; author reply 1018-9. PubMed ID: 14984983
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy for advanced epithelial ovarian carcinoma.
    Kalil NG; McGuire WP
    Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):553-71. PubMed ID: 12413934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Hall TR; Dizon DS
    Clin Adv Hematol Oncol; 2016 Apr; 14(4):262-8. PubMed ID: 27166608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study.
    Machida H; Matsuo K; Enomoto T; Mikami M
    J Gynecol Oncol; 2019 Nov; 30(6):e113. PubMed ID: 31576698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
    Lehoczky O
    Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer.
    Zhao D; Wu LY; Wang XB; Li XG
    Asian Pac J Cancer Prev; 2015; 16(6):2369-73. PubMed ID: 25824766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy in gynaecological cancers - Implications for staging.
    Kumar L; Pramanik R; Kumar S; Bhatla N; Malik S
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):790-801. PubMed ID: 25840650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of bowel perforation after neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Carter J; Durfee J
    Gynecol Oncol; 2007 Dec; 107(3):586-9. PubMed ID: 17949798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy fails to improve survival in advanced ovarian cancer: but is it the real culprit?
    Di Giorgio A; Sammartino P; Biacchi D
    Int J Gynecol Cancer; 2011 May; 21(4):596. PubMed ID: 21543925
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of Pelvic and Para-aortic Lymphadenectomy in Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
    Schwartz L; Schrot-Sanyan S; Brigand C; Baldauf JJ; Wattiez A; Akladios C
    Anticancer Res; 2015 Oct; 35(10):5503-9. PubMed ID: 26408716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.
    Huober J; Meyer A; Wagner U; Wallwiener D
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):153-60. PubMed ID: 11935302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer.
    Markman M
    Gynecol Oncol; 2007 Jul; 106(1):273-4; author reply 274-5. PubMed ID: 17467780
    [No Abstract]   [Full Text] [Related]  

  • 17. Response criteria can be misleading when drawing conclusion regarding neoadjuvant chemotherapy in advanced ovarian cancer.
    Bellati F; Gasparri ML; Caccetta J; Palaia I; Benedetti panici P
    J Surg Oncol; 2012 Sep; 106(4):529; author reply 527-8. PubMed ID: 22488017
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year results of cyclic semi-high dose neoadjuvant chemotherapy supported by autologous peripheral blood stem-cell transplantation in patients with advanced ovarian cancer.
    Ikeba K; Okubo M; Takeda S; Kinoshita K; Maeda H
    Int J Clin Oncol; 2004 Apr; 9(2):113-9. PubMed ID: 15108043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients.
    Cascales-Campos P; Gil J; Gil E; Feliciangeli E; López V; Gonzalez AG; Ruiz-Pardo J; Nieto A; Parrilla P
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():88-93. PubMed ID: 24965986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.